Last edition
News about "Ionis Pharmaceuticals"
Ionis Receives FDA Approval of New Drug Application for Donidalorsen
Donidalorsen is designed to reduce the production of prekallikrein (PKK), interrupting the pathway that leads to HAE attacks.
Ionis Pharmaceuticals | 06/11/2024 | By Aishwarya
Ionis Pharmaceuticals plans California manufacturing site
At an expected 217,000 square feet, the site will be double the size of Ionis' current Carlsbad, California
Ionis Pharmaceuticals | 14/10/2022 | By Sudeep Soparkar | 223
ALS drug by Biogen and Ionis Pharmaceuticals fails in trials
Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after receiving disappointing results from a phase 1 clinical trial.
Ionis Pharmaceuticals | 27/04/2022 | By Sudeep Soparkar | 414
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy